A team of researchers from Mansoura University, Egypt, explored the preventative and therapeutic anticancer properties of Nigella sativa (Black cumin) with surprising results.
In an attempt to find more natural alternative solutions to current chemotherapy courses, scientists decided to test Thymoquinone, an active component found in black cumin, on Ehrlich ascites carcinoma (EAC).
The study concluded that “Thymoquinone could perfectly prevent and/or protect cancer incidence, effectively retarding tumor progress and so, it is significantly recommended to be considered as part of our daily diet. Overall, extra evaluation of Thymoquinone is strongly recommended in clinical fields to outline its possible value to be utilized as an innovative complementary remedy for cancer diseases”.
It is important to mention that all findings were obtained in laboratory conditions. The EAC is an ideal candidate, due to being “an undifferentiated carcinoma with great transplantable ability, quick proliferation, tinier life period and one hundred percent malignancy”, but at the same time, because it is so general, results don’t necessarily translate to real life application.
The article comes on the back of several other papers that had similar claims. If in fact the results can be replicated in clinical trials, this would be an important discovery. Chemotherapy, while efficient, also presents a number of side effects including headaches, muscle and nerve pain, fatigue or even blood disorders. This is why finding natural substitutes is such an important task.
Nevertheless, black cumin does have some proven health benefits and has been used for hundreds of years in the treatment of several diseases and conditions, including for regulating high blood pressure or to reduce high cholesterol.